4//SEC Filing
Kelsey Stephen Michael 4
Accession 0001610717-24-000510
CIK 0001628171other
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 4:07 PM ET
Size
10.7 KB
Accession
0001610717-24-000510
Insider Transaction Report
Form 4
Kelsey Stephen Michael
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2024-10-14$4.09/sh+16,666$68,164→ 281,074 total - Sale
Common Stock
2024-10-14$50.08/sh−2,610$130,702→ 264,408 total - Sale
Common Stock
2024-10-14$49.38/sh−14,056$694,102→ 267,018 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-10-14−16,666→ 23,332 totalExercise: $4.09From: 2023-03-13Exp: 2029-03-12→ Common Stock (16,666 underlying)
Footnotes (4)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024.
- [F2]Includes 86,400 restricted stock units.
- [F3]The transaction was executed in multiple trades in prices ranging from $48.95 to $49.94, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F4]The transaction was executed in multiple trades in prices ranging from $49.95 to $50.27, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Documents
Issuer
Revolution Medicines, Inc.
CIK 0001628171
Entity typeother
Related Parties
1- filerCIK 0001462808
Filing Metadata
- Form type
- 4
- Filed
- Oct 15, 8:00 PM ET
- Accepted
- Oct 16, 4:07 PM ET
- Size
- 10.7 KB